Cargando…
Salivary Redox Biomarkers in Different Stages of Dementia Severity
This study is the first to evaluate oxidative stress biomarkers in saliva/blood of patients with varying degrees of dementia progression. The study included 50 healthy controls and 50 dementia patients divided into two groups: those with mild and moderate dementia (MMSE 11–23) and patients suffering...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617318/ https://www.ncbi.nlm.nih.gov/pubmed/31212834 http://dx.doi.org/10.3390/jcm8060840 |
_version_ | 1783433665197375488 |
---|---|
author | Klimiuk, Anna Maciejczyk, Mateusz Choromańska, Magdalena Fejfer, Katarzyna Waszkiewicz, Napoleon Zalewska, Anna |
author_facet | Klimiuk, Anna Maciejczyk, Mateusz Choromańska, Magdalena Fejfer, Katarzyna Waszkiewicz, Napoleon Zalewska, Anna |
author_sort | Klimiuk, Anna |
collection | PubMed |
description | This study is the first to evaluate oxidative stress biomarkers in saliva/blood of patients with varying degrees of dementia progression. The study included 50 healthy controls and 50 dementia patients divided into two groups: those with mild and moderate dementia (MMSE 11–23) and patients suffering from severe dementia (MMSE 0–10). Cognitive functions of the subjects were assessed using the Mini Mental State Examination (MMSE). Enzymatic and non-enzymatic antioxidants, oxidative damage products and protein glycoxidative modifications were determined in non-stimulated (NWS) and stimulated (SWS) saliva as well as erythrocyte/plasma samples. Generally, in dementia patients, we observed the depletion of antioxidant defences leading to oxidative and glycoxidative damage in NWS, SWS and blood samples. Both salivary and blood oxidative stress increased with the severity of the disease, and correlated with a decrease of cognitive functions. Interestingly, in dementia patients, reduced glutathione (GSH) in NWS correlated not only with the severity of dementia, but also with GSH concentration in the plasma. In receiver operating characteristic (ROC) analysis, we have demonstrated that salivary GSH clearly distinguishes patients with severe dementia from those suffering from mild or moderate dementia (area under the curve (AUC) = 1). Therefore, salivary GSH can be used as a non-invasive biomarker of cognitive impairment. |
format | Online Article Text |
id | pubmed-6617318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66173182019-07-18 Salivary Redox Biomarkers in Different Stages of Dementia Severity Klimiuk, Anna Maciejczyk, Mateusz Choromańska, Magdalena Fejfer, Katarzyna Waszkiewicz, Napoleon Zalewska, Anna J Clin Med Article This study is the first to evaluate oxidative stress biomarkers in saliva/blood of patients with varying degrees of dementia progression. The study included 50 healthy controls and 50 dementia patients divided into two groups: those with mild and moderate dementia (MMSE 11–23) and patients suffering from severe dementia (MMSE 0–10). Cognitive functions of the subjects were assessed using the Mini Mental State Examination (MMSE). Enzymatic and non-enzymatic antioxidants, oxidative damage products and protein glycoxidative modifications were determined in non-stimulated (NWS) and stimulated (SWS) saliva as well as erythrocyte/plasma samples. Generally, in dementia patients, we observed the depletion of antioxidant defences leading to oxidative and glycoxidative damage in NWS, SWS and blood samples. Both salivary and blood oxidative stress increased with the severity of the disease, and correlated with a decrease of cognitive functions. Interestingly, in dementia patients, reduced glutathione (GSH) in NWS correlated not only with the severity of dementia, but also with GSH concentration in the plasma. In receiver operating characteristic (ROC) analysis, we have demonstrated that salivary GSH clearly distinguishes patients with severe dementia from those suffering from mild or moderate dementia (area under the curve (AUC) = 1). Therefore, salivary GSH can be used as a non-invasive biomarker of cognitive impairment. MDPI 2019-06-12 /pmc/articles/PMC6617318/ /pubmed/31212834 http://dx.doi.org/10.3390/jcm8060840 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Klimiuk, Anna Maciejczyk, Mateusz Choromańska, Magdalena Fejfer, Katarzyna Waszkiewicz, Napoleon Zalewska, Anna Salivary Redox Biomarkers in Different Stages of Dementia Severity |
title | Salivary Redox Biomarkers in Different Stages of Dementia Severity |
title_full | Salivary Redox Biomarkers in Different Stages of Dementia Severity |
title_fullStr | Salivary Redox Biomarkers in Different Stages of Dementia Severity |
title_full_unstemmed | Salivary Redox Biomarkers in Different Stages of Dementia Severity |
title_short | Salivary Redox Biomarkers in Different Stages of Dementia Severity |
title_sort | salivary redox biomarkers in different stages of dementia severity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617318/ https://www.ncbi.nlm.nih.gov/pubmed/31212834 http://dx.doi.org/10.3390/jcm8060840 |
work_keys_str_mv | AT klimiukanna salivaryredoxbiomarkersindifferentstagesofdementiaseverity AT maciejczykmateusz salivaryredoxbiomarkersindifferentstagesofdementiaseverity AT choromanskamagdalena salivaryredoxbiomarkersindifferentstagesofdementiaseverity AT fejferkatarzyna salivaryredoxbiomarkersindifferentstagesofdementiaseverity AT waszkiewicznapoleon salivaryredoxbiomarkersindifferentstagesofdementiaseverity AT zalewskaanna salivaryredoxbiomarkersindifferentstagesofdementiaseverity |